Revolutionizing Rosacea Treatment with Microneedle Innovation

This presentation explores the global impact of rosacea, affecting over 437 million people, and its significant psychosocial burden. It addresses clinical features, including diverse phenotypes and the role of VEGF overexpression. Current treatment limitations are highlighted, alongside advancements in understanding vascular dysregulation and preclinical anti-VEGF therapies. An innovative microneedle delivery system offers localised, targeted treatment with minimal systemic exposure. The...